Intragenic amplification of PAX5: a novel subgroup in B-cell precursor acute lymphoblastic leukemia?

ABSTRACT: Intragenic PAX5 amplification defines a novel, relapse-prone subtype of B-cell precursor acute lymphoblastic leukemia with a poor outcome.

SUBMITTER: Schwab C 

PROVIDER: S-EPMC5728462 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature